🔎 Trials Near Me

Почетна › ХОБП › Florida › Miami

Kliničke studije za ХОБП u gradu Miami, FL

20 studija za ХОБП traži učesnike na lokacijama u gradu Miami i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)

Тражи се учесникФаза 3
  • GSK Investigational Site, Miami
Узраст од 40 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07780656

A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

Тражи се учесникФаза 2
  • Copd01 50011, Miami
Узраст од 40 до 80 · Оба пола · Ажурирано 6. 11. 2026. · NCT07725939

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Тражи се учесникФаза 2
  • Millennium Medical Research - Miami, Miami
Узраст од 40 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07759245

Rademikibart IV for Acute Asthma and COPD Exacerbation

Тражи се учесникФаза 2
  • Pharmax Research of South Florida, Inc., Miami
Узраст од 18 до 85 · Оба пола · Ажурирано 4. 11. 2026. · NCT07705737

A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease

Тражи се учесникФаза 2/3
  • Continental Clinical Research, LLC, Miami
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT07908381

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Тражи се учесникФаза 2
  • Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
Узраст од 40 до 85 · Оба пола · Ажурирано 28. 10. 2026. · NCT07684820

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

Тражи се учесникФаза 3
  • GC2501 Study Site 105, Miami
Узраст од 18 до 80 · Оба пола · Ажурирано 26. 10. 2026. · NCT07555483

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Тражи се учесникФаза 2
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
  • и још 2
Узраст 40 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Тражи се учесникФаза 3
  • Elite Clinical Research - Miami- Site Number : 8400167, Miami
  • DL Research Solutions- Site Number : 8400140, Miami
  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
  • и још 3
Узраст од 40 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT07190222

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Тражи се учесникФаза 2/3
  • Reed Medical Research, Miami
Узраст од 35 до 80 · Оба пола · Ажурирано 22. 10. 2026. · NCT07363694

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

Тражи се учесникФаза 4
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
  • Finlay Medical Research- Site Number : 8400010, Miami
Узраст од 40 до 85 · Оба пола · Ажурирано 20. 10. 2026. · NCT07053423

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Тражи се учесникФаза 3
  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
  • MCR Research- Site Number : 8400004, Miami
  • Nuren Medical & Research Center- Site Number : 8400030, Miami
  • и још 2
Узраст од 40 до 80 · Оба пола · Ажурирано 19. 10. 2026. · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Тражи се учесникФаза 3
  • Research Site, Miami
Узраст од 40 до 80 · Оба пола · Ажурирано 9. 10. 2026. · NCT06878261

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Тражи се учесникФаза 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • и још 4
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Тражи се учесникФаза 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Узраст од 40 до 80 · Оба пола · Ажурирано 5. 10. 2026. · NCT06959095

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Тражи се учесникФаза 3
  • Research Site, Miami
  • Research Site, Miami
Узраст од 40 до 80 · Оба пола · Ажурирано 2. 10. 2026. · NCT06283966

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Тражи се учесникФаза 3
  • Research Site, Miami
  • Research Site, Miami
  • Research Site, Miami
Узраст од 40 до 80 · Оба пола · Ажурирано 3. 9. 2026. · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Тражи се учесникФаза 3
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
  • GSK Investigational Site, Miami
Узраст од 40 до 75 · Оба пола · Ажурирано 28. 7. 2026. · NCT07177339

Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD

Тражи се учесник
  • University of Miami, Miami
Узраст од 18 до 100 · Оба пола · Ажурирано 22. 6. 2026. · NCT06578156

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Тражи се учесник
  • Reliable Research, Inc., Miami
  • NewGen Health Group, Miami
Узраст 30 и старији · Оба пола · Ажурирано 6. 2. 2025. · NCT05204888

Studije za ХОБП u drugim gradovima

Ostale studije u gradu Miami

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.